Adiponectin has insulin-sensitizing and anti-inflammation effects, which can stimulate vascular endothelial nitric oxide synthase expression, improve atherogenic lipid profile, selectively inhibits endothelial cell apoptosis, and regulate the NF-κB signaling pathway, thereby slowing the progression of atherosclerosis and cardiovascular events (116). This evidence concerns the gene ADIPOQ and atherosclerosis.